Cancer occurrence after SLE: effects of medication-related factors, disease-related factors, and survival from an observational study.

Qing ZhaoHuazhen LiuWenfang YangZiyue ZhouYiying YangXu JiangHua-Xia YangFengchun Zhang

Published in: Rheumatology (Oxford, England) (2022)

High dosage of CTX and disease-related factors (low SLEDAI-2K, less mucocutaneous and hematologic involvement) were related factors for cancer occurrence after SLE, while no survival difference was observed.

Keyphrases

papillary thyroid
systemic lupus erythematosus
risk assessment
squamous cell
disease activity
healthcare
squamous cell carcinoma
lymph node metastasis
childhood cancer
rheumatoid arthritis
free survival
escherichia coli